Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: A population-based analysis

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 242-249

  Garg, Gunjal ^a   Yee, Cecilia ^b   Schwartz, Kendra ^b   Mutch, David G ^a   Morris, Robert T ^c   Powell, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinosarcoma; Chemotherapy; Outcomes; Patterns of care

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES; UTERINE CARCINOSARCOMA; UTERUS DISEASE;

CARCINOSARCOMA; CHEMOTHERAPY; OUTCOMES; PATTERNS OF CARE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOSARCOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; LYMPH NODE EXCISION; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PELVIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; UTERINE NEOPLASMS;

EID: 84899619782     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.021     Document Type: Article

References (37)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. J. Prat FIGO staging for uterine sarcomas Int J Gynaecol Obstet 104 2009 177 178
3. N. Bansal, T.J. Herzog, V.E. Seshan, P.B. Schiff, W.M. Burke, and C.J. Cohen et al. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior Obstet Gynecol 112 2008 64 70
4. S.N. Nielsen, K.C. Podratz, B.W. Scheithauer, and P.C. O'Brien Clinicopathologic analysis of uterine malignant mixed Mullerian tumors Gynecol Oncol 34 1989 372 378
5. C.A. Leath III, T.M. Numnum, Kendrick JEt, P.J. Frederick, R.P. Rocconi, and M.G. Conner et al. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy Int J Gynecol Cancer 19 2009 888 891
6. B.E. Greer, W.J. Koh, N. Abu-Rustum, M.A. Bookman, R.E. Bristow, and S.M. Campos et al. Uterine neoplasms. Clinical practice guidelines in oncology J Natl Compr Canc Netw 7 2009 498 531
7. A.H. Wolfson, M.F. Brady, T. Rocereto, R.S. Mannel, Y.C. Lee, and R.J. Futoran et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus Gynecol Oncol 107 2007 177 185
8. J.D. Wright, A.I. Neugut, E.T. Wilde, D.L. Buono, J. Malin, and W.Y. Tsai et al. Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer J Clin Oncol 29 2011 3408 3418
9. C.N. Klabunde, J.L. Warren, and J.M. Legler Assessing comorbidity using claims data: an overview Med Care 40 2002 IV-26 IV-35
10. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
11. R.A. Silliman, L. Balducci, J.S. Goodwin, F.F. Holmes, and E.A. Leventhal Breast cancer care in old age: what we know, don't know, and do J Natl Cancer Inst 85 1993 190 199
12. C. Gridelli, P. Maione, A. Rossi, M.L. Ferrara, V. Castaldo, and G. Palazzolo et al. Treatment of advanced non-small-cell lung cancer in the elderly Lung Cancer 66 2009 282 286
13. N.A. Obeidat, F.G. Pradel, I.H. Zuckerman, S. DeLisle, and C.D. Mullins Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer Am J Geriatr Pharmacother 7 2009 343 354
14. J. Zhu, D.B. Sharma, S.W. Gray, A.B. Chen, J.C. Weeks, and D. Schrag Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA 307 2012 1593 1601
15. Z. Nurgalieva, C.C. Liu, and X.L. Du Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer Int J Gynecol Cancer 19 2009 1314 1321
16. V. Sundararajan, D. Hershman, V.R. Grann, J.S. Jacobson, and A.I. Neugut Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study J Clin Oncol 20 2002 173 178
17. A. Jatoi, S. Hillman, P. Stella, E. Green, A. Adjei, and S. Nair et al. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group J Clin Oncol 23 2005 9113 9119
18. S. Greenfield, D.M. Blanco, R.M. Elashoff, and P.A. Ganz Patterns of care related to age of breast cancer patients JAMA 257 1987 2766 2770
19. J. Samet, W.C. Hunt, C. Key, C.G. Humble, and J.S. Goodwin Choice of cancer therapy varies with age of patient JAMA 255 1986 3385 3390
20. S. Giovanazzi-Bannon, A. Rademaker, G. Lai, and A.B. Benson III Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study J Clin Oncol 12 1994 2447 2452
21. J.M. Elston, G.G. Koch, and W.G. Weissert Regression-adjusted small area estimates of functional dependency in the noninstitutionalized American population age 65 and over Am J Public Health 81 1991 335 343
22. J.S. Goodwin, W.C. Hunt, and J.M. Samet A population-based study of functional status and social support networks of elderly patients newly diagnosed with cancer Arch Intern Med 151 1991 366 370
23. K. Lang, M.D. Marciniak, D. Faries, M. Stokes, D. Buesching, and C. Earle et al. Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States Lung Cancer 63 2009 264 270
24. S.D. Ramsey, N. Howlader, R.D. Etzioni, and B. Donato Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare J Clin Oncol 22 2004 4971 4978
25. G.A. Omura, F.J. Major, J.A. Blessing, T.V. Sedlacek, J.T. Thigpen, and W.T. Creasman et al. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas Cancer 52 1983 626 632
26. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 36 44
27. S.A. El-Nashar, and A. Mariani Uterine carcinosarcoma Clin Obstet Gynecol 54 2011 292 304
28. G. Sutton, V.L. Brunetto, L. Kilgore, J.T. Soper, R. McGehee, and G. Olt et al. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study Gynecol Oncol 79 2000 147 153
29. H.D. Homesley, V. Filiaci, M. Markman, P. Bitterman, L. Eaton, and L.C. Kilgore et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study J Clin Oncol 25 2007 526 531
30. P.J. Hoskins, N. Le, S. Ellard, U. Lee, L.A. Martin, and K.D. Swenerton et al. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience Gynecol Oncol 108 2008 58 62
31. L.A. Cantrell, L. Havrilesky, D.T. Moore, D. O'Malley, M. Liotta, and A.A. Secord et al. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma Gynecol Oncol 127 2012 22 26
32. N.S. Reed, C. Mangioni, H. Malmstrom, G. Scarfone, A. Poveda, and S. Pecorelli et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 44 2008 808 818
33. R.A. Nout, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, L.C. Lutgens, and E.M. van der Steen-Banasik et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial J Clin Oncol 27 2009 3547 3556
34. J. Gonzalez Bosquet, S.A. Terstriep, W.A. Cliby, M. Brown-Jones, J.S. Kaur, and K.C. Podratz et al. The impact of multi-modal therapy on survival for uterine carcinosarcomas Gynecol Oncol 116 2010 419 423
35. T.P. Manolitsas, G.V. Wain, K.E. Williams, M. Freidlander, and N.F. Hacker Multimodality therapy for patients with clinical Stage I and II malignant mixed Mullerian tumors of the uterus Cancer 91 2001 1437 1443
36. D. Nemani, N. Mitra, M. Guo, and L. Lin Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis Gynecol Oncol 111 2008 82 88
37. T. Le, A. Adolph, G.V. Krepart, R. Lotocki, and M.S. Heywood The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma Gynecol Oncol 85 2002 351 355